Stockhub

Applied Molecular Transport Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

14 August 2022

11 August 2022

26 July 2022

  • curprev 17:2417:24, 26 July 2022‎ Chris talk contribs‎ 960 bytes +960‎ Created page with "Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It devel..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Applied_Molecular_Transport_Inc.’